Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Standard BioTools Inc (NASDAQ: LAB) was $1.16 for the day, up 0.87% from the previous closing price of $1.15. In other words, the price has increased by $0.87 from its previous closing price. On the day, 1.12 million shares were traded. LAB stock price reached its highest trading level at $1.18 during the session, while it also had its lowest trading level at $1.11.
Ratios:
Our analysis of LAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 16, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $3.50.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.Jefferies initiated its Buy rating on April 04, 2024, with a $3.25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 28 ’25 when Casdin Partners Master Fund, L bought 4,820,959 shares for $1.06 per share. The transaction valued at 5,134,321 led to the insider holds 58,846,780 shares of the business.
Black Jeffrey G. bought 57,971 shares of LAB for $123,098 on Nov 12 ’24. On Sep 09 ’24, another insider, Taich Adam, who serves as the Former Officer of the company, bought 45,851 shares for $2.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 439623744 and an Enterprise Value of 172113312. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.52 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 0.987 whereas that against EBITDA is -1.46.
Stock Price History:
The Beta on a monthly basis for LAB is 1.55, which has changed by -0.56877327 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, LAB has reached a high of $3.04, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -16.17%, while the 200-Day Moving Average is calculated to be -35.06%.
Shares Statistics:
LAB traded an average of 1.94M shares per day over the past three months and 1348780 shares per day over the past ten days. A total of 377.53M shares are outstanding, with a floating share count of 366.94M. Insiders hold about 3.18% of the company’s shares, while institutions hold 73.82% stake in the company. Shares short for LAB as of 1740700800 were 14165972 with a Short Ratio of 7.29, compared to 1738281600 on 12849731. Therefore, it implies a Short% of Shares Outstanding of 14165972 and a Short% of Float of 7.8099996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
